Clinical Trial Update: Measurement of Gastrointestinal (GI) and Health-related Quality of Life (HRQL) Outcomes in Liver Transplant Recipients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating gastrointestinal and health-related quality of life outcomes in liver transplant recipients; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Liver Transplantation | Phase 3 | Status: COMPLETED | Results posted: 2011-03-03